Status:
ACTIVE_NOT_RECRUITING
Smart Phone Delivered Cognitive Behavioral Therapy for Adults With Psoriasis and Co-Morbid Depression Symptoms
Lead Sponsor:
Brigham and Women's Hospital
Collaborating Sponsors:
National Psoriasis Foundation
Conditions:
Psoriasis
Depressive Symptoms
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A single arm, pilot study in which all eligible participants will be enrolled in an 8-week coach-guided smartphone delivered CBT program. The full duration of the program, with follow-up interview, wi...
Detailed Description
1. To demonstrate the feasibility and acceptability of coach-guided, smartphone-delivered CBT for depression among adults with psoriasis 2. To demonstrate the preliminary efficacy of coach-guided, sma...
Eligibility Criteria
Inclusion
- • Adults aged 18 years of age and older
- Dermatologist confirmed diagnosis of psoriasis
- Current depression symptoms, defined as a PHQ-9 score of 5 or greater
- Current psoriasis symptoms, defined as a scaled score of "mild" on any of the Skindex-16 subscales
- Participants must be proficient in English and have access to an Android or iOS smartphone
Exclusion
- Previous participation in CBT for depression
- Current participation in any type of psychotherapy
- Those on psychotropic medications must be taking a stable dose for 2 months prior to enrollment and be willing to remain at a stable dose during the 8-week study
- Current elevated suicide risk (see Section 5.3 for details)
- Individuals who are incarcerated or compulsory detained
- Any uncontrolled or poorly controlled chronic medical condition that may interfere with an individual's ability to participate in the clinical trial
Key Trial Info
Start Date :
January 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06216691
Start Date
January 1 2024
End Date
December 31 2025
Last Update
September 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115